Sponsored by:

Nuclear Medicine: Page 250

GE adds to molecular imaging line
By AuntMinnie.com staff writers
GE Healthcare is highlighting a number of new developments with its molecular imaging portfolio at this week's European Association of Nuclear Medicine congress in Vienna.
October 11, 2010
ImaginAb teams with Imanet
By AuntMinnie.com staff writers
Imaging agent developer ImaginAb and GE Healthcare unit Imanet have inked a master service agreement for preclinical and clinical imaging.
October 10, 2010
PETNet opens new biomarker facility
By AuntMinnie.com staff writers
Siemens Healthcare subsidiary PETNet Solutions has opened an imaging biomarker production facility in Madrid.
October 10, 2010
PETNet expands biomarker production
By AuntMinnie.com staff writers
PETNet Solutions is expanding its imaging biomarker production capabilities in Nottingham, England, to enhance its ability to produce new biomarkers as investigational medicine products in the U.K.
October 7, 2010
ASNC's Carter passes away
By AuntMinnie.com staff writers
Steven Carter, executive director of the American Society of Nuclear Cardiology (ASNC) of Bethesda, MD, passed away September 20.
October 7, 2010
Siemens debuts HD-Chest for PET/CT
By AuntMinnie.com staff writers
Siemens Healthcare has introduced HD-Chest, a new technology designed to reduce blur created by respiration during PET/CT studies.
October 7, 2010
NRC probes Mo-99 snafu at Walter Reed
By AuntMinnie.com staff writers
The U.S. Nuclear Regulatory Commission (NRC) is investigating how Walter Reed Army Medical Center in Washington, DC, allegedly mishandled the delivery of 1.5 Ci of molybdenum-99 (Mo-99) and 71 mCi of thallium-201 by leaving the two packages in the lobby for two days.
October 7, 2010
Study updates dose estimates for rubidium-82 cardiac PET
By Wayne Forrest
Rubidium-82 is increasingly being used for cardiac PET imaging, but radiation dose estimates for the exams are based on old -- and conflicting -- data. Researchers from Johns Hopkins University offer updated dose estimates for rubidium-82 procedures in a study published in the October issue of the Journal of Nuclear Medicine.
October 7, 2010
2010 10 01 14 40 24 993 Rubidium Bengel 01 Thumb
Dilon reports positive BSGI study
By AuntMinnie.com staff writers
Breast-specific gamma imaging (BSGI) developer Dilon Diagnostics said that new research has found BSGI to be nearly twice as effective in finding breast cancers than ultrasound, and more than three times as likely to lead to a correct diagnosis.
October 6, 2010
Neoprobe wraps up pre-NDA meeting
By AuntMinnie.com staff writers
Gamma camera probe developer Neoprobe said it has completed a pre-new drug application (NDA) assessment with the U.S. Food and Drug Administration for its Lymphoseek radiopharmaceutical agent.
October 6, 2010
Wis. groups receive Mo-99 grants
By AuntMinnie.com staff writers
Two groups from Wisconsin have received $500,000 each from the U.S. Department of Energy to develop technologies to manufacture molybdenum-99 (Mo-99).
October 4, 2010
Dilon touts low radiation in BSGI study
By AuntMinnie.com staff writers
Breast-specific gamma imaging (BSGI) developer Dilon Diagnostics said that research presented at the recent Chicago International Breast Course showed promising early results from using a low dose of sestamibi in BSGI studies.
October 4, 2010
Previous Page
Page 250 of 440
Next Page